sector intelligence Measured conclusion Latest qualified tape

Sector Sentiment Dossier

Healthcare sentiment intelligence

Company-news tone, narrative breadth, confidence, catalyst concentration and market confirmation examined as separate evidence layers.

Constructive but selective 56/100 narrative breadth 76/100 evidence confidence 2490 qualified equities from 3442 latest records
Peer rank4 of 14weighted group score
Qualified coverage72%952 records withheld
Direct evidence92%48713 company matches
Story dispersion4.4cross-company score spread
Relative to context+0.6versus Global qualified tape
Latest refresh12 Aug 202623636 publisher signals

Executive Evidence Brief

A balanced headline masks a selective company tape

Aggregate tone remains near neutral, so breadth, catalysts and company-level outliers carry more information than the headline score alone.

Directional score53.0weighted polarity, separate from reliability
Breadth56constructive minus cautious participation
Confidence76depth, directness, freshness and agreement

Evidence that supports the read

Constructive participation reaches 56/100 across qualified company reads.

Evidence confidence is 76/100 across 2490 qualified equities.

Direct company coverage supplies 92% of the measured article set.

Positive one-week price responses appear across 55% of measured equities.

Conditions that limit conviction

No material evidence constraint is currently dominant.

Narrative Breadth

How widely tone is shared

2490 equities
56Breadth
Constructive31612.7%
Balanced214085.9%
Cautious341.4%

Score Distribution

Shape of the company tape

Neutral range 43 to 57
1Strong caution
33Cautious
2140Balanced
302Constructive
14Strongly constructive

Evidence Quality

Reliability of the read

Confidence is not polarity
76/100 group confidence
High confidence1628
Usable evidence349
Developing513

52899 relevant story observations across 23636 publisher signals. 92% is direct company evidence.

13-Week Trajectory

Weighted tone and participation

Completed observations only
15 Jun: tone 53.8, breadth 58.2, 170 observations22 Jun: tone 53.6, breadth 56.4, 179 observations29 Jun: tone 53.5, breadth 56.7, 179 observations06 Jul: tone 53.0, breadth 56.1, 180 observations13 Jul: tone 53.3, breadth 56.3, 174 observations20 Jul: tone 53.4, breadth 56.7, 180 observations27 Jul: tone 53.1, breadth 55.0, 180 observations03 Aug: tone 53.7, breadth 56.3, 119 observations10 Aug: tone 55.8, breadth 70.3, 180 observations 100500
18 May29 Jun10 Aug
Weighted toneNarrative breadthNeutral 50

The path uses a fixed quality sample of up to 180 current constituents to keep the historical query reproducible. Earlier observations are not rewritten by later headlines.

Market Confirmation

How price is responding to the news tape

2490 securities measured

Price response is a diagnostic cross-check. It does not alter the sentiment score, so agreement and disagreement remain visible.

Confirmed by price1647% of qualified equities
News-price disagreement115646% of qualified equities
Cautious news absorbed141% of qualified equities
No decisive price test115646% of qualified equities
Median 1W return+0.90%
Median 4W return-1.20%
Positive 1W response55%
Active trend signal33%
Above Fair Value41%
Median Fair Value gap-7.80%

Internal Leadership

Country map

31 qualified groups

4 thin groups are withheld because they contain fewer than 5 qualified securities.

Narrative Dispersion

Industry map

11 qualified groups

Peer Comparison

Where this read sits in the ranked tape

Rank 4 of 14

Catalyst Lens

What is moving the narrative

Latest company observations
Market update152961.4% of equities · tone 52.6
Earnings86134.6% of equities · tone 53.7
Deals and strategy441.8% of equities · tone 53.7
Analyst action170.7% of equities · tone 55.6
Guidance140.6% of equities · tone 52.8
Capital return130.5% of equities · tone 53.5
Regulatory and legal100.4% of equities · tone 40.2
Balance sheet20.1% of equities · tone 49.6

Publisher Lens

Where the latest observations came from

Not an independence count
TradingView50320.2% of equities · tone 51.3
simplywall.st1957.8% of equities · tone 53.5
TradingKey1917.7% of equities · tone 52.8
MarketBeat1726.9% of equities · tone 53.9
TipRanks1084.3% of equities · tone 51.6
Market source1064.3% of equities · tone 51.7
Stock Titan973.9% of equities · tone 52.8
marketscreener.com823.3% of equities · tone 51.8

Positioning Lens

What deserves attention

Score rank#4among 14 measured sectors
Parent spread+0.6versus Global qualified tape
Cross-company dispersion4.4higher values mean a less uniform tape

Security Evidence

The equities behind the read

Open any ticker for its complete dossier

Constructive leaders

Shofu Inc.

News confirmed by price · +1.0% 1W

Earnings · 59/100 confidence · 6 direct stories
Tsumura & Co.

Balanced read · +0.5% 1W

Earnings · 24/100 confidence · 2 direct stories
Medtronic plc

Balanced read · +0.5% 1W

Earnings · 82/100 confidence · 12 direct stories
Johnson & Johnson

Balanced read · +0.7% 1W

Earnings · 79/100 confidence · 10 direct stories
BeOne Medicines AG

Balanced read · +0.0% 1W

Earnings · 48/100 confidence · 4 direct stories
Beijing Strong Biotechnologies,Inc.

Positive news being faded · -2.8% 1W

Earnings · 56/100 confidence · 6 direct stories
MDT67
Medtronic PLC

News confirmed by price · +2.1% 1W

Earnings · 93/100 confidence · 31 direct stories
JNJ67
Johnson & Johnson

Positive news being faded · -1.0% 1W

Earnings · 91/100 confidence · 19 direct stories

Cautious laggards

Capricor Therapeutics Inc

Bad news being absorbed · +6.2% 1W

Regulatory and legal · 90/100 confidence · 38 direct stories
ARS Pharmaceuticals, Inc

Bad news being absorbed · +20.1% 1W

Earnings · 86/100 confidence · 22 direct stories
ADMA Biologics Inc

Bad news being absorbed · +2.3% 1W

Regulatory and legal · 80/100 confidence · 49 direct stories
Austar Lifesciences Limited

Balanced read · -0.7% 1W

Earnings · 42/100 confidence · 2 direct stories
RGC38
Regencell Bioscience Holdings Ltd

Bad news being absorbed · +8.0% 1W

Market update · 77/100 confidence · 39 direct stories
Regeneron Pharmaceuticals, Inc.

Bad news being absorbed · +3.6% 1W

Market update · 59/100 confidence · 7 direct stories
Novavax, Inc.

Caution confirmed by price · -5.3% 1W

Earnings · 24/100 confidence · 2 direct stories
Alignment Healthcare LLC

Caution confirmed by price · -3.2% 1W

Earnings · 85/100 confidence · 49 direct stories

Attention leaders

ACB57
Aurora Cannabis Inc

Price moving ahead of tone · +4.5% 1W

Market update · 75/100 confidence · 60 direct stories
OGN56
Organon & Co

Balanced read · +0.2% 1W

Market update · 75/100 confidence · 60 direct stories
Alkermes Plc

Price moving ahead of tone · -7.4% 1W

Earnings · 75/100 confidence · 60 direct stories
Bausch + Lomb Corp

Price moving ahead of tone · +4.6% 1W

Earnings · 75/100 confidence · 60 direct stories
Healthcare Services Group Inc

Balanced read · +2.5% 1W

Market update · 75/100 confidence · 60 direct stories
TAK56
Takeda Pharmaceutical Co Ltd ADR

Balanced read · -0.9% 1W

Market update · 75/100 confidence · 60 direct stories
MOH48
Molina Healthcare Inc

Balanced read · -1.0% 1W

Market update · 75/100 confidence · 60 direct stories
Avita Medical Ltd

Price moving ahead of tone · -4.6% 1W

Market update · 75/100 confidence · 60 direct stories

Latest Evidence Ledger

Recent company-level observations

18 displayed

Ascentage Pharma Group International (NASDAQ:AAPG) Sets New 12-Month Low - What's Next?

MarketBeat · Market update · News confirmed by price

87/100 confidence · 96% direct evidence

Erasca (NASDAQ:ERAS) Given New $22.00 Price Target at HC Wainwright

MarketBeat · Earnings · Balanced read

88/100 confidence · 97% direct evidence

Here Are Wednesday’s Top Wall Street Analyst Research Calls: The Gap, Genmab, Hilton Worldwide, Intuitive Surgical, Mariott International, Merck, Novo Nordisk, Okta, and More

24/7 Wall St. · Earnings · Price moving ahead of tone

84/100 confidence · 100% direct evidence
UNH65

UnitedHealth declares $2.32 dividend

seekingalpha.com · Earnings · Positive news being faded

93/100 confidence · 100% direct evidence

BrainsWay (NASDAQ: BWAY) boosts 2026 guidance after 35% jump in Q2 revenue

Stock Titan · Earnings · Balanced read

89/100 confidence · 100% direct evidence

Industry Analysts Just Upgraded Their Alector, Inc. (NASDAQ:ALEC) Revenue Forecasts By 60%

simplywall.st · Earnings · Price moving ahead of tone

87/100 confidence · 98% direct evidence

HC Wainwright Has Positive Estimate for SLDB Q3 Earnings

MarketBeat · Earnings · News confirmed by price

90/100 confidence · 98% direct evidence

Regeneron, Tenet leads top healthcare companies with highest earnings beats (XLV:NYSEARCA)

Seeking Alpha · Earnings · Balanced read

85/100 confidence · 100% direct evidence

Regeneron, Tenet leads top healthcare companies with highest earnings beats (XLV:NYSEARCA)

Seeking Alpha · Earnings · Price moving ahead of tone

75/100 confidence · 100% direct evidence

Regeneron, Tenet leads top healthcare companies with highest earnings beats (XLV:NYSEARCA)

Seeking Alpha · Earnings · Balanced read

71/100 confidence · 100% direct evidence

Why is Sagimet Biosciences stock climbing today? By Investing.com

Investing.com Canada · Market update · Price moving ahead of tone

90/100 confidence · 97% direct evidence

Is Immunic Inc (IMUX) Struggling After Recent Earnings? EPS Misses Estimates with GF Score: 32/100

GuruFocus · Earnings · Balanced read

85/100 confidence · 98% direct evidence

Autolus Q2 Net Loss Narrows As AUCATZYL Sales Surge 119%; CARLYSLE Data Expected By Year-End

nasdaq.com · Earnings · News confirmed by price

91/100 confidence · 99% direct evidence

BioNTech (BNTX) Stock Looks Reasonable On Sales But Stretched On Value

simplywall.st · Earnings · Balanced read

88/100 confidence · 99% direct evidence

Annex Advisory Services LLC Raises Stock Position in Intuitive Surgical, Inc. $ISRG

MarketBeat · Market update · News confirmed by price

93/100 confidence · 100% direct evidence
A63

Stock futures little changed as traders await inflation report

seekingalpha.com · Market update · News confirmed by price

89/100 confidence · 100% direct evidence

IVD Raw Materials Market Report (2025-2034) Published — Assesses Demand Across Pharma, Biotech, Diagnostic Laboratories, and CROs

GlobeNewswire · Earnings · News confirmed by price

78/100 confidence · 100% direct evidence

Assenagon Asset Management S.A. Buys New Shares in Repligen Corporation $RGEN

MarketBeat · Earnings · Price moving ahead of tone

88/100 confidence · 100% direct evidence

Reproducible Method

How to read this dossier

Direction

The score measures the polarity of qualified published news after relevance, source quality, event importance and freshness weighting. It is centred at 50.

Breadth

Breadth measures how widely constructive or cautious classifications are shared. A few extreme equities cannot create broad participation.

Confidence

Confidence measures sample depth, direct-company coverage, publisher diversity, freshness and agreement. It is intentionally separate from direction.

Market confirmation

Completed weekly price data tests whether the market confirms, rejects or absorbs the narrative. Price never feeds back into the sentiment score.

Coverage controls

Unqualified ticker records are excluded, and subgroup maps require at least five qualified securities. Thin slices are disclosed instead of ranked.

Interpretation

This is a current evidence classification, not a forecast, target, recommendation or measure of investor positioning.

Evidence context